ILAE-Europe
News
About ILAE
Epilepsia Open® Call for Applications 2023
Epilepsia Open® will provide one-year internships to the editorial board, as well as a one-year position to the editorial board for a member of the epilepsy community to serve as a Living Experience Editor, starting August 2023.
30 May, 2023
About ILAE
ILAE survey on genetic testing in the epilepsies
Genetic testing in the epilepsies continues to gain importance, however access differs significantly across healthcare settings. This ILAE survey seeks to establish the state of genetic testing worldwide.
11 May, 2023
About ILAE
Climate Change – Attitudes and Actions Survey for epilepsy professionals and researchers
The objective of this survey from the ILAE Climate Change Commission is to collect baseline data on knowledge, perception and awareness of epilepsy professionals and researchers about climate change and its impact on daily life, as well as on their professional activities and people with epilepsy.
19 April, 2023
Clinical Research
Rates of Status Epilepticus and Sudden Unexplained Death in Epilepsy in People With Genetic Developmental and Epileptic Encephalopathies
Abstract Background and Objectives The genetic developmental and epileptic encephalopathies (DEEs) comprise a large group of severe epilepsy syndromes, with a wide phenotypic spectrum. Currently, the rates of convulsive status epilepticus (CSE), nonconvulsive status epilepticus (NCSE), and…
18 April, 2023
About ILAE
Epilepsy Nurses for Switzerland
The Swiss League Against Epilepsy is launching a pilot project to train and introduce specialist epilepsy nurses throughout Switzerland and is looking for project partners. | La Ligue Suisse contre l’Epilepsie souhaite former en conséquence du personnel qualifié et le déployer dans toute la Suisse dans le cadre d’un projet pilote. Pour cela, elle recherche des partenaires.
30 March, 2023
Subscribe to the ILAE Newsletter
To subscribe, please click on the button below.
Please send me information about ILAE activities and other
information of interest to the epilepsy community